 |
Home > Pharma
More companies now days are facing compound hydration difficulties. Can you and your company afford not having the best technology out there?
One of the greatest challenges of any novel drug formulation is the hydration step – how to hydrate the API while maintaining maximum activity with a minimum level of toxicity. Several approaches were utilized to reach both goals, however, many times the concentration of the solvent was too toxic for clinical use and the promising on-paper compound never reached pre-clinical/clinical trials. Today, drug development and drug formulation can be made easy through the use of Neowater®. On this page you will find all the relevant information regarding the Pharma-related opportunities, as well as detailed reports, media information, articles etc. If you have questions or interested in our technology, you are invited to contact us and send us your question/query – we will respond quickly and efficiently!
Neowater – hydration application
Neowater - Hydration application will allow you to develop new water based formulations with your hydrophobic , hydrophilic or difficult-to-solvate compounds,
Important note: Neowater has been assigned with a DMF number (20503) - for cross reference, see the DMF listing (as of August 15, 2007) and the FDA site.
Key benefits of the Neowater:
- Replaces most or all organic solvents in a formulation, with Neowater based formulation
- Disperses difficult-to-solvate hydrophobic active compounds
- Maintains active compound stability and enhances bioavailability
- Enables to reformulate a mix of hydrophilic and hydrophobic compound
- Minimizes formulation toxicity or side effects such as immune system reactions
- Allows Pharma companies to reformulate and thus extend IP rights or have new IP
- Allows for arms-length in vitro and/or in vivo testing of compounds
 |
| About Us | Core technology | Pharma | BioPharma | Diagnostics | News | Contact us | Site map | Resources | Drug Delivery Articles |
 |
|
All Rights Reserved to Do-Coop Technologies Ltd - A
drug development and
Drug formulation Company that developed an Innovatinve
drug delivery system called - NeowaterŪ.
Docoop drug delivery system covers Hydrophobic compounds, solubilization service, Small molecule solubilization, Antibody stabilization, Protein stabilization, Enzyme stabilization, Stem cell viability, Stem cell growth, Cell line viability, Cell line growth, Stem cells media and Cell line cryopreservation. With Docoop the formulation of drugs is a fast, high quality and time saving process. Learn here about Solubilization, Cryopreservation and Drug screening. | 
Encountered with a broken link or other Website malfunction? Please contact the Site Administrator This site is best viewed on Internet explorer version 5.5 or higher |